Open access
Open access
Powered by Google Translator Translator

Archives

More data suggests no cardiovascular benefit from Omega-3 supplementation – secondary analysis of STRENGHT trial did not show an association between achieved Omega-3 fatty acid levels and major adverse cardiovascular outcomes in patients with high cardiovascular risk.

8 Jun, 2021 | 09:19h | UTC

Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial – JAMA Cardiology

Original study: #AHA20 – Randomized trial: High-dose Omega-3 fatty acids did not reduce the risk of cardiac events in patients at high cardiovascular risk

Commentaries: Higher blood levels of omega-3 fatty acids from prescription fish oil showed no effect on CV events – American College of Cardiology

 


RCT: Heart-protecting drugs likely unnecessary for most breast cancer patients undergoing adjuvant treatment.

8 Jun, 2021 | 09:15h | UTC

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA) Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol – Circulation

Commentaries: Heart-protecting drugs likely unnecessary for many breast cancer patients – American College of Cardiology

 


RCT: In patients hospitalized with Covid-19 with elevated D-Dimer, a full-dose anticoagulation strategy based on rivaroxaban (full-dose heparins in unstable patients) + rivaroxaban to day 30 was not better than prophylactic anticoagulation and increased bleeding risk.

7 Jun, 2021 | 00:01h | UTC

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial – The Lancet

Related: #ACC21 – [Not published yet] RCT: Among hospitalized patients with Covid-19 and elevated D-Dimer, therapeutic anticoagulation with Rivaroxaban 20 mg was not associated with improved outcomes and resulted in increased major bleeding.

 

Commentary on Twitter

https://twitter.com/RenatoDLopes1/status/1400962037610582026

 


Six months of COVID vaccines: what 1.7 billion doses have taught scientists.

6 Jun, 2021 | 23:57h | UTC

Six months of COVID vaccines: what 1.7 billion doses have taught scientists – Nature

See also: Coronavirus (COVID-19) Vaccinations – Our World in Data

 

Related commentary on Twitter

 


Review: Management of patients with venous thromboembolism after the initial treatment period.

8 Jun, 2021 | 09:13h | UTC

Management of Patients With Venous Thromboembolism After the Initial Treatment Period – The Journal of the American Board of Family Medicine

 


WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic.

6 Jun, 2021 | 23:56h | UTC

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic – Nature

Related: WHO validates Sinovac-CoronaVac COVID-19 vaccine for emergency use and issues interim policy recommendations. AND Brazilian town experiment shows mass vaccination can wipe out COVID-19.

 


Study shows reduced neutralizing antibody activity induced by Pfizer–BioNTech vaccine against SARS-CoV-2 variants of concern B.1.617.2 (Delta) and B.1.351 (Beta).

6 Jun, 2021 | 23:59h | UTC

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2  and B.1.351 (Beta) by BNT162b2 vaccination – The Lancet

Commentary: Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant – The Francis Crick Institute

 

Commentary on Twitter (thread – click for more)

 


Case report: Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).

6 Jun, 2021 | 23:55h | UTC

Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) – Journal of Thrombosis and Haemostasis

Commentary: COVID-19 vaccination: Thrombosis can be prevented by prompt treatment, researchers report – Medical University of Vienna

 


More data on the harmful effects of the COVID-19 pandemic on the mental health of adolescents.

6 Jun, 2021 | 23:52h | UTC

Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study – The Lancet Psychiatry

Commentaries: A lost generation? COVID-19 and adolescent mental health – The Lancet Psychiatry AND COVID-19 pandemic has had significant impact on the mental health of adolescents – Columbia University Mailman School of Public Health

 

Commentary on Twitter (thread – click for more)

https://twitter.com/TheLancetPsych/status/1400783180937011202

 


2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19.

6 Jun, 2021 | 23:54h | UTC

Neurologic, psychiatric conditions common in COVID-19 – CIDRAP

Meta-analysis 1: Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives – Journal of Neurology, Neurosurgery & Psychiatry

Meta-analysis 2: Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings – BMC Infectious Diseases

Related: Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditions

 


Challenges and solutions for physician mothers: a critical review of the literature.

6 Jun, 2021 | 23:46h | UTC

Challenges and Solutions for Physician Mothers: A Critical Review of the Literature – Mayo Clinic Proceedings

 

Commentary on Twitter

 


Perspective | Could statins do more than lower cholesterol in patients with COVID-19? – “Don’t Start, Don’t Stop”.

6 Jun, 2021 | 23:49h | UTC

Could Statins Do More Than Lower Cholesterol in Patients With COVID-19? – JAMA

 


Opinion | “Doctors have been blamed for the rise in black fungus in India, but the COVID treatment guidelines could be contributing” – improper use of antibiotics and higher than usual doses of corticosteroids may be contributing to the emergence of mucormycosis and other fungal co-infections.

6 Jun, 2021 | 23:48h | UTC

Doctors have been blamed for the rise in black fungus in India, but the COVID treatment guidelines could be contributing – The Conversation

See also: Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? – The Lancet Respiratory Medicine

Related: The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries – The Lancet AND What Is ‘Black Fungus’? And Why Is It Spreading Among India’s COVID Patients? – NPR AND Mucormycosis: The ‘black fungus’ maiming Covid patients in India AND What is mucormycosis, the fungal infection affecting COVID patients in India? – The Conversation

 


RCT: Early, intensive mobilization poststroke may harm patients.

6 Jun, 2021 | 23:45h | UTC

Fatal and Nonfatal Events Within 14 days After Early, Intensive Mobilization Poststroke – Neurology

 


Moving from bytes to bedside: a systematic review on the use of artificial intelligence in the intensive care unit.

6 Jun, 2021 | 23:42h | UTC

Moving from bytes to bedside: a systematic review on the use of artificial intelligence in the intensive care unit – Intensive Care Medicine

 

Commentary on Twitter

 


M-A: Direct comparison of preoperative imaging modalities for localization of primary hyperparathyroidism – “choline PET-CT would be the best preoperative imaging modality for localization of primary hyperparathyroidism”.

6 Jun, 2021 | 23:40h | UTC

Direct Comparison of Preoperative Imaging Modalities for Localization of Primary Hyperparathyroidism: A Systematic Review and Network Meta-analysis –

JAMA Otolaryngology – Head & Neck Surgery (free for a limited period)

Invited commentary: Localization Studies for Parathyroid Surgery (free for a limited period)

 


Investigation | Covid 19: How harm reduction advocates and the tobacco industry capitalized on the pandemic to promote nicotine.

6 Jun, 2021 | 23:51h | UTC

Covid 19: How harm reduction advocates and the tobacco industry capitalised on the pandemic to promote nicotine – The BMJ

Commentaries: Researchers report how the tobacco and e-cigarette industry capitalized on COVID-19 to promote smoking – News Medical AND Investigation discredits studies suggesting lower COVID-19 risk for smokers

 


M-A: The benefit of dysphagia screening in adult patients with stroke.

6 Jun, 2021 | 23:43h | UTC

The Benefit of Dysphagia Screening in Adult Patients With Stroke: A Meta‐Analysis – Journal of the American Heart Association

 


Update on the diagnosis and treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome.

6 Jun, 2021 | 23:37h | UTC

Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review – JAMA Oncology (free for a limited period)

 


Viewpoint | A national goal to advance health equity through value-based payment.

6 Jun, 2021 | 23:39h | UTC

A National Goal to Advance Health Equity Through Value-Based Payment – JAMA

Related: Report: Implementing high-quality primary care – “pay for primary care teams to care for people, not physicians to deliver services”.

 


Another study shows a high frequency of antibiotic use among patients hospitalized with Covid-19 (85.2%), despite low rates of confirmed secondary bacterial infections.

4 Jun, 2021 | 10:43h | UTC

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study – The Lancet Microbe

Commentaries: Very high use of antibiotics in COVID-19 treatment could be reduced – University of Glasgow AND More evidence of frequent antibiotic use noted in COVID patients – CIDRAP AND Covid-19: Antimicrobial use was high during first wave despite bacterial co-infections being rare, study finds – The BMJ

Related: Many hospitalized Covid-19 patients are given antibiotics. That’s a problem – STAT

 

Commentary on Twitter (thread – click for more)

 


M-A: Prehospital Tranexamic Acid reduces mortality among bleeding trauma patients without increasing the risk of venous thromboembolism.

6 Jun, 2021 | 23:34h | UTC

The impact of prehospital TXA on mortality among bleeding trauma patients: A systematic review and meta-analysis – Journal of Trauma and Acute Care Surgery (link to abstract – $ for full-text)

Commentary: Prehospital TXA for Trauma – Meta-analysis – JournalFeed

 


RCT: No benefit from posterior quadratus lumborum block in total hip arthroplasty.

6 Jun, 2021 | 23:35h | UTC

Posterior Quadratus Lumborum Block in Total Hip Arthroplasty: A Randomized Controlled Trial – Anesthesiology

 

Commentary on Twitter

 


Cohort study: long working hours (more than 55 h/week) linked to increased risk of recurrent coronary events.

6 Jun, 2021 | 23:32h | UTC

Long Working Hours and Risk of Recurrent Coronary Events – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentaries: Working long hours may increase odds of second heart attack – American College of Cardiology AND Recurrent CHD Risk Up With Long Working Hours After First MI – HealthDay AND Longer Work Hours After MI Tied to Higher Risk of Recurrent Events – TCTMD

 


In a Mendelian randomization study, researchers found no genetic evidence to support an association between Vitamin D levels and COVID-19 susceptibility, severity, or hospitalization.

4 Jun, 2021 | 10:35h | UTC

Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study – PLOS Medicine

Commentary: Vitamin D may not provide protection from COVID-19 susceptibility or disease severity, study suggests – PLOS

Related: Living systematic review: The evidence is insufficient to determine the benefits and harms of vitamin D supplementation as a treatment of COVID‐19. AND RCT: Vitamin D3 does not improve outcomes in hospitalized patients with moderate to severe COVID-19

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.